Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine as adjuvant therapy for adolescents with major depressive disorder on sertraline
IRCT20250111064353N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mirtazapine in major depressive disorder (MDD), sponsored by Shiraz University of Medical Sciences. Started Apr 2025; status: completed.
02
Drugs
mirtazapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20250111064353N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250111064353N1.